- Rachel Hanford, a third-year medical oncology resident, received the Edward L. Gillette Memorial Award for Outstanding Research Poster Presentation.
- The award was presented at the annual Veterinary Cancer Society Conference.
- Hanford studied whether prophylactic metronidazole could reduce clinically relevant diarrhea in dogs receiving doxorubicin chemotherapy.
- The study found prophylactic metronidazole was associated with a reduced need for rescue therapy for clinically relevant chemotherapy-induced diarrhea.
- The research was funded by the Center for Companion Animal Health at the UC Davis Weill School of Veterinary Medicine.
Rachel Hanford, a third-year resident in medical oncology, received the Edward L. Gillette Memorial Award for Outstanding Research Poster Presentation at the annual Veterinary Cancer Society Conference.
Hanford’s research examined the use of prophylactic metronidazole to address chemotherapy-induced diarrhea in dogs receiving doxorubicin. Doxorubicin is a standard chemotherapy drug that can cause diarrhea, potentially affecting a dog’s quality of life and delaying cancer treatment.
Evaluating preventive treatment
The prospective, randomized, double-blinded, placebo-controlled study evaluated whether administering metronidazole before the onset of clinical signs could reduce clinically relevant diarrhea.
The study concluded that prophylactic metronidazole was associated with a reduced need for rescue therapy for clinically relevant chemotherapy-induced diarrhea in dogs undergoing doxorubicin treatment. The preventive approach also produced a measurable reduction in severe gastrointestinal complications.
The research was funded by a grant from the Center for Companion Animal Health, a small animal research center at the UC Davis Weill School of Veterinary Medicine.
Research award
The Edward L. Gillette Memorial Award was established in memory of Edward L. Gillette, DVM, PhD, a pioneering figure in veterinary and comparative radiation oncology.
Information sourced from the company’s press release.
